Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 31, 2015 11:43 PM ET

Healthcare Equipment and Supplies

Company Overview of Kinetic Concepts, Inc.

Company Overview

Kinetic Concepts, Inc. develops wound healing technologies, medicines, and therapies for caregivers, healthcare professionals, and patients in the United States and internationally. It offers V.A.C., a wound healing modality that delivers negative pressure wound therapy for healing; V.A.C.Ulta, a negative pressure wound therapy system; ABThera, an open abdomen negative pressure therapy; and Prevena, a negative pressure product for the management of closed surgical incisions that continue to drain following sutured or stapled closure. The company also offers Graftjacket, a regenerative tissue matrix for the repair or replacement of damaged or inadequate integumental tissue, such as diabetic f...

12930 Interstate Highway 10 West

San Antonio, TX 78249

United States

Founded in 1976

Phone:

210-524-9000

Fax:

210-255-6998

Key Executives for Kinetic Concepts, Inc.

Chief Executive Officer, President and Director
Age: 48
Interim Chief Financial Officer, Vice President and Corporate Controller
Senior Vice President of Operations
Age: 54
President of Kci Volunteer Council
Group President of Businesses and Innovation
Age: 40
Compensation as of Fiscal Year 2014.

Kinetic Concepts, Inc. Key Developments

Kinetic Concepts, Inc. and KCI USA, Inc. Enter Amendment to Senior Secured Credit Facility

Kinetic Concepts, Inc. and KCI USA, Inc. entered into Amendment to Senior Secured Credit Facility. The certain applicable rates were modified so that Dollar Term E-1 Loans bear interest at a rate equal to, at KCI's election, a Eurocurrency rate plus 3.50% or an adjusted base rate plus 2.50%; Euro Term E-1 Loans bear interest at a rate equal to, at KCI's election, a Eurocurrency rate plus 3.75% or an adjusted base rate plus 2.75%, and Term E-2 Loans bear interest at a rate equal to, at KCI's election, a Eurocurrency rate plus 3.00% or an adjusted base rate plus 2.00%. The Eurocurrency rate shall be subject to a floor of 1.00%, and the adjusted base rate shall be subject to a floor of 2.00%. Repayments of Dollar Term E-1 Loans, Euro Term E-1 Loans or Term E-2 Loans within 12 months of the effective date of Amendment in connection with a repricing transaction will be subject to a 1.0% prepayment premium.

Centaur Guernsey L.P. Inc. Announces Executive Changes

Centaur Guernsey L.P. Inc. announced that Robert Hureau, Executive Vice President and Chief Financial Officer for Centaur and each of its operating subsidiaries Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited, has notified the company that he will be resigning to pursue another career opportunity. Mr. Hureau will continue in his current role until September 23, 2014. Following Mr. Hureau's departure, Brian Busenlehner, Vice President, Corporate Controller, will serve as interim Chief Financial Officer, working closely with President and CEO Joe Woody and the company's senior leadership team on all financial matters. Mr. Busenlehner has served as Vice President, Controller since 2007 and in that role has been responsible for global accounting, financial consolidation and external reporting in addition to providing leadership in support of the company's Global Shared Service Center in Budapest, Hungary.

Kinetic Concepts, Inc. Announces Settlement and Release Agreement with Wake Forest University Health Sciences

Kinetic Concepts, Inc. entered into a settlement and release agreement with Wake Forest University Health Sciences to fully and finally resolve the pending patent disputes between them regarding Wake Forest's negative pressure wound therapy (NPWT) patents formerly licensed to KCI. The Settlement Agreement resolves all disputes between KCI and Wake Forest, and their respective affiliates, related to Wake Forest's NPWT patents that were the subject of a 1993 license agreement between KCI and Wake Forest. To fully resolve all the pending disputes between KCI and Wake Forest, KCI agreed to pay Wake Forest retrospective U.S. patent royalties in the amount of $280 million, according to the following schedule: $80 million to be paid in July, 2014, $85 million to be paid in June 2015, $85 million to be paid in June 2016, and $30 million to be paid in June, 2017. The Settlement Agreement includes a stipulated dismissal with prejudice of the lawsuits between KCI and Wake Forest, including the lawsuit that was previously scheduled to begin trial on July 28, 2014 in the U.S. District Court for the Western District of Texas, San Antonio Division.

Similar Private Companies By Industry

Company Name Region
Total Resources International Inc. United States
Cincinnati Sub-Zero Products, Inc. United States
Pacific Device, Inc. United States
Pluromed, Inc. United States
MedPro Investments LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kinetic Concepts, Inc., please visit www.kci1.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.